Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.

Sommat K, Hussain A, Ong WS, Yit NLF, Khoo JBK, Soong YL, Wee JTS, Fong KW, Tan TWK.

Radiother Oncol. 2019 Sep;138:149-157. doi: 10.1016/j.radonc.2019.05.023. Epub 2019 Jun 29.

PMID:
31265972
2.

Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials.

Chen YP, Tang LL, Yang Q, Poh SS, Hui EP, Chan ATC, Ong WS, Tan T, Wee J, Li WF, Chen L, Ma BBY, Tong M, Tan SH, Cheah SL, Fong KW, Sommat K, Soong YL, Guo Y, Lin AH, Sun Y, Hong MH, Cao SM, Chen MY, Ma J.

Clin Cancer Res. 2018 Apr 15;24(8):1824-1833. doi: 10.1158/1078-0432.CCR-17-2656. Epub 2018 Feb 5.

3.

Impact of comorbidity on tolerability and survival following curative intent intensity modulated radiotherapy in older patients with nasopharyngeal cancer.

Sommat K, Yit NLF, Wang F, Lim JHC.

J Geriatr Oncol. 2018 Jul;9(4):352-358. doi: 10.1016/j.jgo.2018.01.006. Epub 2018 Feb 9.

PMID:
29429963
4.

Prognostic Model for Stratification of Radioresistant Nasopharynx Carcinoma to Curative Salvage Radiotherapy.

Li YQ, Tian YM, Tan SH, Liu MZ, Kusumawidjaja G, Ong EHW, Zhao C, Tan TWK, Fong KW, Sommat K, Soong YL, Wee JTS, Han F, Chua MLK.

J Clin Oncol. 2018 Mar 20;36(9):891-899. doi: 10.1200/JCO.2017.75.5165. Epub 2018 Feb 7.

PMID:
29412781
5.

Thyroid V40 Predicts Primary Hypothyroidism After Intensity Modulated Radiation Therapy for Nasopharyngeal Carcinoma.

Sommat K, Ong WS, Hussain A, Soong YL, Tan T, Wee J, Fong KW.

Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):574-580. doi: 10.1016/j.ijrobp.2017.03.007. Epub 2017 Mar 14.

PMID:
28581397
6.

Comparison of Circulating Tumour Cells and Circulating Cell-Free Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy.

Vo JH, Nei WL, Hu M, Phyo WM, Wang F, Fong KW, Tan T, Soong YL, Cheah SL, Sommat K, Low H, Ling B, Ng J, Tan WL, Chan KS, Oon L, Ying JY, Tan MH.

Sci Rep. 2016 Dec 19;6(1):13. doi: 10.1038/s41598-016-0006-3.

7.

A 13-Year Single Institutional Experience with Definitive Radiotherapy in Hypopharyngeal Cancer.

Sommat K, Yong SK, Fong KW, Tan TW, Wee JT, Soong YL.

Ann Acad Med Singapore. 2017 Jan;46(1):32-36. No abstract available.

8.

Comparison between 4-MV and 6-MV radiotherapy in T1N0 glottic cancer.

Sommat K, Yit NL, Kwok LL.

Laryngoscope. 2017 May;127(5):1061-1067. doi: 10.1002/lary.26067. Epub 2016 May 30.

PMID:
27237064

Supplemental Content

Loading ...
Support Center